Please provide your email address to receive an email when new articles are posted on . Psoriasis patients who self-administer bimekizumab experienced similar levels of comfort and success with both ...
IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Herbert Busher, a physician in St ...
The Aidaptus ® disposable auto-injector platform, designed by Owen Mumford, will be jointly offered to global biopharma companies to support their drug development programs with engineering and ...
Diabetes drugmaker Xeris Pharmaceuticals made a $75 million bet last summer when it went public to back an FDA submission for its shelf-stable glucagon injector pen. Now, more than a year later, Xeris ...
The two companies signed an exclusive collaboration agreement for the Aidaptus auto-injector. Owen Mumford, a medical device manufacturer, announced on May 4, 2022 that it has signed an exclusive ...
Industry first single-use auto-injector for both 1ml and 2.25 pre-filled syringes with versatile design for different fill volumes in the same device. Aidaptus has an innovative, patient-centric ...
The new Syrina 2.25 is a compact auto-injector that uses the standard 2.25 mL prefilled syringe, based on Bespak’s proprietary VapourSoft technology. Drug-delivery company, Bespak, is launching its ...
The patients suffering from chronic disease require a regular dose of medicines, either orally or as injections. The patients prefer the self-injection method as it is easy to use, cost-effective, and ...
AbbVie GK, Eisai Co. and EA Pharma Co. have debuted the HUMIRA Pen, an auto-injector pen meant to help simplify self-injection. The product, which has a rounded pen-type body designed to help patients ...
Elayne Gordonov, Market Manager - Global Bio Market at Instron, talks to AZoM about physical testing requirements of syringes, Luer connections, and needle-based injection systems in-line with ISO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results